Sponsor Check › Person
Related person on Form D filings · address states as listed: CA, IA, TX, GA, NJ, MA · listed Aug 3, 2009 → Jan 8, 2016
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
6 of 32 offerings report sales commissions totalling $7,736,620; 2 report finder's fees totalling $1,393,500; 3 report proceeds to related persons totalling $1,984,890. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Dec 16, 2022 D/A File 021-467630 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 29, 2022 D File 021-443811 | $0 | $793,500 (est.) | $0 | None listed on this filing |
| EDGAR ↗ | Jan 7, 2022 D File 021-428418 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 20, 2021 D File 021-425970 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 21, 2021 D File 021-396550 | $0 | $0 | $1,046,890 | None listed on this filing |
| EDGAR ↗ | Jun 5, 2018 D File 021-313867 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 18, 2017 D File 021-287056 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 27, 2017 D File 021-283388 | $0 (est.) | $0 | $0 (est.) Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. | None listed on this filing |
| EDGAR ↗ | Dec 5, 2016 D File 021-275654 | $385,000 (est.) | $0 | $0 (est.) Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. | H.C. WainWright & Co., LLC BrokerCheck CRD 375 ↗ |
| EDGAR ↗ | May 25, 2016 D File 021-263863 | $350,000 (est.) | $0 | $0 (est.) Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. | H.C. WainWright & Co., LLC BrokerCheck CRD 375 ↗ |
| EDGAR ↗ | Jan 8, 2016 D/A File 021-225542 | $0 | $0 | $478,000 (est.) Working capital including salaries for officers | None listed on this filing |
| EDGAR ↗ | Sep 15, 2015 D File 021-247677 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 11, 2014 D File 021-229941 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 30, 2014 D File 021-225540 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 4, 2014 D File 021-224060 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 9, 2014 D File 021-217129 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 30, 2014 D File 021-210971 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 17, 2013 D File 021-203013 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 14, 2013 D File 021-198008 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 22, 2013 D/A File 021-192052 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 12, 2013 D File 021-193086 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 14, 2012 D File 021-188439 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 7, 2012 D File 021-183758 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 28, 2012 D File 021-175766 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 2, 2011 D File 021-168169 | $210,000 (est.) | $0 (est.) | $0 | Monarch Capital Group, Inc. no CRD number reported CIM Securities, LLC no CRD number reported |
| EDGAR ↗ | Oct 26, 2011 D File 021-167841 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 9, 2011 D/A File 021-155547 | $105,000 (est.) | $0 (est.) | $0 | Monarch Capital Group, Inc. no CRD number reported Antaeus Capital, Inc. no CRD number reported |
| EDGAR ↗ | Nov 1, 2010 D/A File 021-148200 | $6,620,620 | $0 | $460,000 | Garden State Securities, Inc. BrokerCheck CRD 10083 ↗ via Portfolio Advisors Alliance, Inc. (CRD 101680 ↗) Felix Investments, LLC BrokerCheck CRD 148441 ↗ Allen Partners BrokerCheck CRD 36518 ↗ via Portfolio Advisors Alliance, Inc. (CRD 101680 ↗) |
| EDGAR ↗ | Oct 18, 2010 D File 021-149246 | $66,000 (est.) | $0 | $0 | Monarch Capital Group LLC no CRD number reported |
| EDGAR ↗ | Aug 3, 2010 D/A File 021-143748 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 18, 2010 D File 021-134238 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 3, 2009 D File 021-72767-2C | $0 | $600,000 (est.) | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Telemynd, Inc. | Director | Dec 16, 2022 | D/A | $6,000,001 similar: $829,831–$9,999,998 | $6,000,001 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Telemynd, Inc. | Director | Dec 15, 2022 | D | $6,000,001 similar: $829,831–$9,999,998 | $6,000,001 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | OneroRx, Inc. | Director | Apr 29, 2022 | D | $20,000,000 similar: $500,000–$7,000,000 | $20,000,000 | 75 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Inseer Inc. | Director | Jan 7, 2022 | D | Indefinite similar: $500,000–$7,000,000 | $0 | 0 similar: 2–14 | $100,000 similar: $5,000–$50,000 |
| EDGAR ↗ | ConnectRN, Inc. | Director | Dec 20, 2021 | D | $76,037,981 similar: $829,831–$9,999,998 | $75,037,982 | 25 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | ConnectRN, Inc. | Director | Apr 21, 2021 | D | $13,362,161 similar: $1,100,015–$10,001,163 | $13,143,672 | 19 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | ConnectRN, Inc. | Director | Jun 5, 2018 | D | $11,527,049 similar: $829,831–$9,999,998 | $11,527,049 | 23 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | ConnectRN, Inc. | Director | May 18, 2017 | D | $2,525,000 similar: $1,100,015–$10,001,163 | $2,525,000 | 14 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | CANCER GENETICS, INC | Director | Mar 27, 2017 | D | $6,000,000 similar: $2,000,000–$19,999,994 | $6,000,000 | 3 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | CANCER GENETICS, INC | Director | Dec 5, 2016 | D | $5,500,000 similar: $2,000,000–$19,999,994 | $5,500,000 | 16 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | CANCER GENETICS, INC | Director | May 25, 2016 | D | $5,000,000 similar: $2,000,000–$19,999,994 | $5,000,000 | 41 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Jan 8, 2016 | D/A | $6,000,000 similar: $829,831–$9,999,998 | $4,000,000 | 15 similar: 2–15 | $5,000 similar: $10,000–$54,310 |
| EDGAR ↗ | American CareSource Holdings, Inc. | Executive Officer, Director | Sep 15, 2015 | D | $510,000 similar: $829,831–$9,999,998 | $510,000 | 3 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Jul 2, 2015 | D/A | $3,000,000 similar: $829,831–$9,999,998 | $2,265,000 | 9 similar: 2–15 | $5,000 similar: $10,000–$54,310 |
| EDGAR ↗ | American CareSource Holdings, Inc. | Director | Dec 11, 2014 | D | $2,601,600 similar: $829,831–$9,999,998 | $2,601,600 | 3 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Sep 30, 2014 | D | $2,500,000 similar: $829,831–$9,999,998 | $1,550,000 | 7 similar: 2–15 | $5,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Sep 30, 2014 | D | $1,000,000 similar: $829,831–$9,999,998 | $260,000 | 6 similar: 2–15 | $5,000 similar: $10,000–$54,310 |
| EDGAR ↗ | American CareSource Holdings, Inc. | Director | Sep 4, 2014 | D | $2,520,000 similar: $1,500,000–$10,000,000 | $2,520,000 | 7 similar: 1–11 | No minimum reported similar: $25,000–$100,000 |
| EDGAR ↗ | American CareSource Holdings, Inc. | Director | May 9, 2014 | D | $2,000,000 similar: $829,831–$9,999,998 | $2,000,000 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Jan 30, 2014 | D | $1,000,000 similar: $829,831–$9,999,998 | $415,000 | 9 similar: 2–15 | $5,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Sep 17, 2013 | D | $2,000,000 similar: $829,831–$9,999,998 | $221,549 | 5 similar: 2–15 | $5,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Jun 14, 2013 | D | $2,000,000 similar: $829,831–$9,999,998 | $72,500 | 4 similar: 2–15 | $10,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Syncbak, Inc. | Director | May 22, 2013 | D/A | $2,000,000 similar: $500,000–$7,000,000 | $2,000,000 | 11 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Mar 12, 2013 | D | $2,500,000 similar: $829,831–$9,999,998 | $595,000 | 16 similar: 2–15 | $10,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Syncbak, Inc. | Director | Feb 19, 2013 | D | $1,000,000 similar: $500,000–$7,000,000 | $1,000,000 | 7 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Dec 14, 2012 | D | $135,846 similar: $829,831–$9,999,998 | $135,846 | 3 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Sep 7, 2012 | D | $2,000,000 similar: $829,831–$9,999,998 | $300,000 | 4 similar: 2–15 | $50,000 similar: $10,000–$54,310 |
| EDGAR ↗ | St. Gregory Centers Holdings, LLC | Director Manager | Mar 28, 2012 | D | $1,000,101 similar: $829,831–$9,999,998 | $1,000,101 | 2 similar: 2–15 | $100,010 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Nov 2, 2011 | D | $2,000,000 similar: $829,831–$9,999,998 | $270,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Oct 26, 2011 | D | $0 similar: $829,831–$9,999,998 | $0 | 19 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | May 9, 2011 | D/A | $2,500,000 similar: $829,831–$9,999,998 | $2,500,000 | 12 similar: 2–15 | $50,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Feb 17, 2011 | D | $5,000,000 similar: $829,831–$9,999,998 | $450,000 | 5 similar: 2–15 | $50,000 similar: $10,000–$54,310 |
| EDGAR ↗ | CANCER GENETICS, INC | Director | Nov 1, 2010 | D/A | $10,000,000 similar: $2,000,000–$19,999,994 | $6,618,000 | 42 similar: 2–16 | $10,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Oct 18, 2010 | D | $3,050,000 similar: $829,831–$9,999,998 | $1,611,688 | 4 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | CANCER GENETICS, INC | Director | Sep 27, 2010 | D | $12,000,000 similar: $2,000,000–$19,999,994 | $6,618,000 | 42 similar: 2–16 | $10,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Aug 3, 2010 | D/A | $1,000,000 similar: $829,831–$9,999,998 | $750,000 | 3 similar: 2–15 | $125,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Jun 18, 2010 | D | $500,000 similar: $829,831–$9,999,998 | $500,000 | 1 similar: 2–15 | $500,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Mar 18, 2010 | D | $1,000,000 similar: $829,831–$9,999,998 | $1,000,000 | 1 similar: 2–15 | $1,000,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Mar 17, 2010 | D | $400,000 similar: $829,831–$9,999,998 | $200,000 | 1 similar: 2–15 | $200,000 similar: $10,000–$54,310 |
| EDGAR ↗ | Emmaus Life Sciences, Inc. group: Emmaus Life Sciences | Director | Mar 17, 2010 | D | $500,000 similar: $829,831–$9,999,998 | $500,000 | 2 similar: 2–15 | $250,000 similar: $10,000–$54,310 |
| EDGAR ↗ | SPECTRASCIENCE INC | Director | Aug 3, 2009 | D | $5,000,000 similar: $2,000,000–$19,999,994 | $930,000 | 8 similar: 2–16 | $25,000 similar: $10,000–$50,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (5 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as John Pappajohn. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when John Pappajohn appears on a new Form D, or when a court case or SEC action is matched to them. See plans →